Endo International (ENDP) Tops Q2 EPS by 31c, Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Endo Reports Second-Quarter 2020 Financial Results
August 5, 2020 4:30 PM EDTRevenues decreased 2% to $688 million compared to prior year
On July 6, 2020, U.S. FDA approved Qwo (collagenase clostridium histolyticum-aaes), the first injectable treatment for cellulite
DUBLIN, Aug. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second quarter ended June 30, 2020.
